中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 4
Apr.  2024
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(4): 822-827

Role of the Hedgehog signaling pathway in hepatocellular carcinoma and its tumor microenvironment

DOI: 10.12449/JCH240429
  • 1.

    Department of Integrated Traditional Chinese and Western Medicine，Beijing Ditan Hospital，Capital Medical University，Beijing 100102，China

  • 2.

    Department of Infectious Diseases，Shanxi Bethune Hospital，Taiyuan 030021，China

Research funding:

State Administration of Traditional Chinese Medicine High-level Key Discipline Construction Project of Traditional Chinese Medicine (zyyzdxk-2023005);

Capital Health Development Research Project (2024-1-2173)

More Information
  • Corresponding author: WANG Xianbo， wangxb@ccmu.edu.cn （ORCID： 0000-0002-3593-5741）
  • Received Date: 2023-06-28
  • Accepted Date: 2023-10-07
  • Published Date: 2024-04-25
    Abstract
  • The Hedgehog （Hh） signaling pathway plays an important role in the development and progression of hepatocellular carcinoma and its tumor microenvironment， and abnormal activation of Hh signal can accelerate the growth of tumor. The crosstalk between the Hh signaling pathway and TME is closely associated with tumor growth and the formation of inhibitory tumor microenvironment. Evidence shows that inhibition of Hh signal plays an important role in inhibiting the growth of hepatocellular carcinoma. This article reviews the current research status of the role， mechanism， and potential therapeutic significance of abnormal activation of Hh signal in hepatocellular carcinoma and its tumor microenvironment， so as to provide new ideas for the treatment of hepatocellular carcinoma.

     

    • FullText(HTML)
  • loading
    • References(62)
  • [1]
    LLOVET JM, KELLEY RK, VILLANUEVA A, et al. Hepatocellular carcinoma[J]. Nat Rev Dis Primers, 2021, 7( 1): 6. DOI: 10.1038/s41572-020-00240-3.
    [2]
    KHANAM A, KOTTILIL S. New therapeutics for HCC: Does tumor immune microenvironment matter?[J]. Int J Mol Sci, 2022, 24( 1): 437. DOI: 10.3390/ijms24010437.
    [3]
    WU T, DAI Y. Tumor microenvironment and therapeutic response[J]. Cancer Lett, 2017, 387: 61- 68. DOI: 10.1016/j.canlet.2016.01.043.
    [4]
    AMAKYE D, JAGANI Z, DORSCH M. Unraveling the therapeutic potential of the Hedgehog pathway in cancer[J]. Nat Med, 2013, 19( 11): 1410- 1422. DOI: 10.1038/nm.3389.
    [5]
    PETTY AJ, LI A, WANG XY, et al. Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment[J]. J Clin Invest, 2019, 129( 12): 5151- 5162. DOI: 10.1172/JCI128644.
    [6]
    ZHANG JH, FAN JJ, ZENG X, et al. Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment[J]. Acta Pharm Sin B, 2021, 11( 3): 609- 620. DOI: 10.1016/j.apsb.2020.10.022.
    [7]
    NÜSSLEIN-VOLHARD C, WIESCHAUS E. Mutations affecting segment number and polarity in Drosophila[J]. Nature, 1980, 287( 5785): 795- 801. DOI: 10.1038/287795a0.
    [8]
    JIANG J. Hedgehog signaling mechanism and role in cancer[J]. Semin Cancer Biol, 2022, 85: 107- 122. DOI: 10.1016/j.semcancer.2021.04.003.
    [9]
    PORTER JA, EKKER SC, PARK WJ, et al. Hedgehog patterning activity: Role of a lipophilic modification mediated by the carboxy-terminal autoprocessing domain[J]. Cell, 1996, 86( 1): 21- 34. DOI: 10.1016/s0092-8674(00)80074-4.
    [10]
    BRISCOE J, THÉROND PP. The mechanisms of Hedgehog signalling and its roles in development and disease[J]. Nat Rev Mol Cell Biol, 2013, 14( 7): 416- 429. DOI: 10.1038/nrm3598.
    [11]
    RYAN KE, CHIANG C. Hedgehog secretion and signal transduction in vertebrates[J]. J Biol Chem, 2012, 287( 22): 17905- 17913. DOI: 10.1074/jbc.R112.356006.
    [12]
    GAO LL, ZHANG ZY, ZHANG P, et al. Role of canonical Hedgehog signaling pathway in liver[J]. Int J Biol Sci, 2018, 14( 12): 1636- 1644. DOI: 10.7150/ijbs.28089.
    [13]
    OCHOA B, SYN WK, DELGADO I, et al. Hedgehog signaling is critical for normal liver regeneration after partial hepatectomy in mice[J]. Hepatology, 2010, 51( 5): 1712- 1723. DOI: 10.1002/hep.23525.
    [14]
    ZHU CY, TABAS I, SCHWABE RF, et al. Maladaptive regeneration-the reawakening of developmental pathways in NASH and fibrosis[J]. Nat Rev Gastroenterol Hepatol, 2021, 18( 2): 131- 142. DOI: 10.1038/s41575-020-00365-6.
    [15]
    HUANG SH, HE J, ZHANG XL, et al. Activation of the hedgehog pathway in human hepatocellular carcinomas[J]. Carcinogenesis, 2006, 27( 7): 1334- 1340. DOI: 10.1093/carcin/bgi378.
    [16]
    KIM Y, YOON JW, XIAO XK, et al. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells[J]. Cancer Res, 2007, 67( 8): 3583- 3593. DOI: 10.1158/0008-5472.CAN-06-3040.
    [17]
    JENG KS, SHEEN IS, JENG WJ, et al. High expression of patched homolog-1 messenger RNA and glioma-associated oncogene-1 messenger RNA of sonic hedgehog signaling pathway indicates a risk of postresection recurrence of hepatocellular carcinoma[J]. Ann Surg Oncol, 2013, 20( 2): 464- 473. DOI: 10.1245/s10434-012-2593-y.
    [18]
    CHEN JS, HUANG XH, WANG Q, et al. Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/AKT signaling-mediated activation of matrix metalloproteinase(MMP)-2 and MMP-9 in liver cancer[J]. Carcinogenesis, 2013, 34( 1): 10- 19. DOI: 10.1093/carcin/bgs274.
    [19]
    HE J, ZUO QZ, HU B, et al. A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA[J]. Cancer Lett, 2019, 450: 98- 109. DOI: 10.1016/j.canlet.2019.02.033.
    [20]
    HUANG XH, CHEN JS, WANG Q, et al. miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened[J]. J Pathol, 2011, 225( 3): 463- 472. DOI: 10.1002/path.2877.
    [21]
    CHOI SS, OMENETTI A, WITEK RP, et al. Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis[J]. Am J Physiol Gastrointest Liver Physiol, 2009, 297( 6): G1093- G1106. DOI: 10.1152/ajpgi.00292.2009.
    [22]
    GU Y, WANG YY, HE LY, et al. Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via Hedgehog signaling[J]. Mol Cancer, 2021, 20( 1): 132. DOI: 10.1186/s12943-021-01435-2.
    [23]
    BEACHY PA, HYMOWITZ SG, LAZARUS RA, et al. Interactions between Hedgehog proteins and their binding partners come into view[J]. Genes Dev, 2010, 24( 18): 2001- 2012. DOI: 10.1101/gad.1951710.
    [24]
    ANDERSON NM, SIMON MC. The tumor microenvironment[J]. Curr Biol, 2020, 30( 16): R921- R925. DOI: 10.1016/j.cub.2020.06.081.
    [25]
    XIAO Y, YU DH. Tumor microenvironment as a therapeutic target in cancer[J]. Pharmacol Ther, 2021, 221: 107753. DOI: 10.1016/j.pharmthera.2020.107753.
    [26]
    LIU TY, HAN CC, WANG SW, et al. Cancer-associated fibroblasts: An emerging target of anti-cancer immunotherapy[J]. J Hematol Oncol, 2019, 12( 1): 86. DOI: 10.1186/s13045-019-0770-1.
    [27]
    CHEN XM, SONG EW. Turning foes to friends: Targeting cancer-associated fibroblasts[J]. Nat Rev Drug Discov, 2019, 18( 2): 99- 115. DOI: 10.1038/s41573-018-0004-1.
    [28]
    KALLURI R. The biology and function of fibroblasts in cancer[J]. Nat Rev Cancer, 2016, 16( 9): 582- 598. DOI: 10.1038/nrc.2016.73.
    [29]
    BU LK, BABA H, YOSHIDA N, et al. Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment[J]. Oncogene, 2019, 38( 25): 4887- 4901. DOI: 10.1038/s41388-019-0765-y.
    [30]
    WILL AJ, COVA G, OSTERWALDER M, et al. Composition and dosage of a multipartite enhancer cluster control developmental expression of Ihh(Indian hedgehog)[J]. Nat Genet, 2017, 49( 10): 1539- 1545. DOI: 10.1038/ng.3939.
    [31]
    GONG X, QIAN HW, CAO PP, et al. Structural basis for the recognition of Sonic Hedgehog by human Patched1[J]. Science, 2018, 361( 6402): eaas8935. DOI: 10.1126/science.aas8935.
    [32]
    HUANG PX, ZHENG SD, WIERBOWSKI BM, et al. Structural basis of smoothened activation in hedgehog signaling[J]. Cell, 2018, 175( 1): 295- 297. DOI: 10.1016/j.cell.2018.09.003.
    [33]
    ZHANG Y, FU L, QI XL, et al. Structural insight into the mutual recognition and regulation between suppressor of fused and Gli/Ci[J]. Nat Commun, 2013, 4: 2608. DOI: 10.1038/ncomms3608.
    [34]
    INFANTE P, FAEDDA R, BERNARDI F, et al. Itch/β-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesis[J]. Nat Commun, 2018, 9( 1): 976. DOI: 10.1038/s41467-018-03339-0.
    [35]
    LEX RK, JI ZC, FALKENSTEIN KN, et al. GLI transcriptional repression regulates tissue-specific enhancer activity in response to Hedgehog signaling[J]. eLife, 2020, 9: e50670. DOI: 10.7554/eLife.50670.
    [36]
    MILENKOVIC L, SCOTT MP. Not lost in space: Trafficking in the hedgehog signaling pathway[J]. Sci Signal, 2010, 3( 117): pe14. DOI: 10.1126/scisignal.3117pe14.
    [37]
    VON AHRENS D, BHAGAT TD, NAGRATH D, et al. The role of stromal cancer-associated fibroblasts in pancreatic cancer[J]. J Hematol Oncol, 2017, 10( 1): 76. DOI: 10.1186/s13045-017-0448-5.
    [38]
    SAITO RA, MICKE P, PAULSSON J, et al. Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer[J]. Cancer Res, 2010, 70( 7): 2644- 2654. DOI: 10.1158/0008-5472.CAN-09-3644.
    [39]
    VALENTI G, QUINN HM, HEYNEN GJJE, et al. Cancer stem cells regulate cancer-associated fibroblasts via activation of hedgehog signaling in mammary gland tumors[J]. Cancer Res, 2017, 77( 8): 2134- 2147. DOI: 10.1158/0008-5472.CAN-15-3490.
    [40]
    CAZET AS, HUI MN, ELSWORTH BL, et al. Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer[J]. Nat Commun, 2018, 9( 1): 2897. DOI: 10.1038/s41467-018-05220-6.
    [41]
    JIANG NX, XIA JW, JIANG B, et al. Retraction notice to“TUG1 alleviates hypoxia injury by targeting miR-124 in H9c2 cells”[Biomed. Pharmacother. 103(2018) 1669-1677][J]. Biomed Pharmacother, 2022, 150: 112856. DOI: 10.1016/j.biopha.2022.112856.
    [42]
    LIU J, CHEN S, WANG W, et al. Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways[J]. Cancer Lett, 2016, 379( 1): 49- 59. DOI: 10.1016/j.canlet.2016.05.022.
    [43]
    ATHAR M, LI CX, TANG XW, et al. Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of Fas expression and apoptosis[J]. Cancer Res, 2004, 64( 20): 7545- 7552. DOI: 10.1158/0008-5472.CAN-04-1393.
    [44]
    THAYER SP, DI MAGLIANO MP, HEISER PW, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis[J]. Nature, 2003, 425( 6960): 851- 856. DOI: 10.1038/nature02009.
    [45]
    PATIL MA, ZHANG J, HO C, et al. Hedgehog signaling in human hepatocellular carcinoma[J]. Cancer Biol Ther, 2006, 5( 1): 111- 117. DOI: 10.4161/cbt.5.1.2379.
    [46]
    VITALE I, MANIC G, COUSSENS LM, et al. Macrophages and metabolism in the tumor microenvironment[J]. Cell Metab, 2019, 30( 1): 36- 50. DOI: 10.1016/j.cmet.2019.06.001.
    [47]
    MAZZONE M, MENGA A, CASTEGNA A. Metabolism and TAM functions-it takes two to tango[J]. FEBS J, 2018, 285( 4): 700- 716. DOI: 10.1111/febs.14295.
    [48]
    ANDREJEVA G, RATHMELL JC. Similarities and distinctions of cancer and immune metabolism in inflammation and tumors[J]. Cell Metab, 2017, 26( 1): 49- 70. DOI: 10.1016/j.cmet.2017.06.004.
    [49]
    MOVAHEDI K, LAOUI D, GYSEMANS C, et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes[J]. Cancer Res, 2010, 70( 14): 5728- 5739. DOI: 10.1158/0008-5472.CAN-09-4672.
    [50]
    WANG XC, LU XJ, SUN BC. The pros and cons of dying tumour cells in adaptive immune responses[J]. Nat Rev Immunol, 2017, 17( 9): 591. DOI: 10.1038/nri.2017.87.
    [51]
    PHILIP M, SCHIETINGER A. CD8+ T cell differentiation and dysfunction in cancer[J]. Nat Rev Immunol, 2022, 22( 4): 209- 223. DOI: 10.1038/s41577-021-00574-3.
    [52]
    PETTY AJ, DAI R, LAPALOMBELLA R, et al. Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function[J]. JCI Insight, 2021, 6( 6): e146707. DOI: 10.1172/jci.insight.146707.
    [53]
    TAN JZ, FAN WZ, LIU T, et al. TREM2+ macrophages suppress CD8+ T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma[J]. J Hepatol, 2023, 79( 1): 126- 140. DOI: 10.1016/j.jhep.2023.02.032.
    [54]
    MULLOR JL, SÁNCHEZ P, ALTABA ARI. Pathways and consequences: Hedgehog signaling in human disease[J]. Trends Cell Biol, 2002, 12( 12): 562- 569. DOI: 10.1016/S0962-8924(02)02405-4.
    [55]
    LEE J, PLATT KA, CENSULLO P, et al. Gli1 is a target of Sonic hedgehog that induces ventral neural tube development[J]. Development, 1997, 124( 13): 2537- 2552. DOI: 10.1242/dev.124.13.2537.
    [56]
    CHEN JS, LI HS, HUANG JQ, et al. Down-regulation of Gli-1 inhibits hepatocellular carcinoma cell migration and invasion[J]. Mol Cell Biochem, 2014, 393( 1-2): 283- 291. DOI: 10.1007/s11010-014-2071-x.
    [57]
    QUAGLIO D, INFANTE P, DI MARCOTULLIO L, et al. Hedgehog signaling pathway inhibitors: An updated patent review(2015-present)[J]. Expert Opin Ther Pat, 2020, 30( 4): 235- 250. DOI: 10.1080/13543776.2020.1730327.
    [58]
    LORUSSO PM, RUDIN CM, REDDY JC, et al. Phase I trial of hedgehog pathway inhibitor vismodegib(GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors[J]. Clin Cancer Res, 2011, 17( 8): 2502- 2511. DOI: 10.1158/1078-0432.CCR-10-2745.
    [59]
    RUDIN CM, HANN CL, LATERRA J, et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449[J]. N Engl J Med, 2009, 361( 12): 1173- 1178. DOI: 10.1056/NEJMoa0902903.
    [60]
    SEKULIC A, MIGDEN MR, ORO AE, et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma[J]. N Engl J Med, 2012, 366( 23): 2171- 2179. DOI: 10.1056/NEJMoa1113713.
    [61]
    PINTER M, SIEGHART W, SCHMID M, et al. Hedgehog inhibition reduces angiogenesis by downregulation of tumoral VEGF-A expression in hepatocellular carcinoma[J]. United European Gastroenterol J, 2013, 1( 4): 265- 275. DOI: 10.1177/2050640613496605.
    [62]
    WANG Y, HAN C, LU L, et al. Hedgehog signaling pathway regulates autophagy in human hepatocellular carcinoma cells[J]. Hepatology, 2013, 58( 3): 995- 1010. DOI: 10.1002/hep.26394.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (429) PDF downloads(55) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return